Mouse Wnt-5a Biotinylated Antibody

Catalog #: BAF645
9 Citations Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
BAF645

All Wnt-5a Antibodies

Product Details

Citations (9)

Supplemental Products

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Mouse Wnt-5a Biotinylated Antibody Summary

Species Reactivity

Mouse

Specificity

Detects mouse Wnt-5a in Western blots. In this format, approximately 2% cross-reactivity with recombinant mouse Wnt‑4 is observed.

Source

Polyclonal Goat IgG

Purification

Antigen Affinity-purified

Immunogen

E. coli-derived recombinant mouse Wnt‑5a peptide
Gln254-Cys334
Accession # P22725

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Label

Biotin

Applications

Recommended Concentration

Sample

Western Blot

0.1 µg/mL

Recombinant Mouse Wnt‑5a (Catalog # 645-WN)

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Wnt-5a

Wnt proteins are secreted glycoproteins that contain a conserved pattern of 23 - 24 cysteine residues. Wnts play critical roles in both carcinogenesis and embryonic development for a variety of organisms. Wnts bind to receptors of the Frizzled family, sometimes in conjunction with other membrane-associated proteins such as LRPs or proteoglycans. Downstream effects of Wnt signaling occur through different intracellular components, depending on which pathway is activated. Three pathways have been characterized: the canonical Wnt/ beta -catenin pathway, the Wnt/Ca²⁺ pathway, and the planar cell polarity (1 - 2).

Wnt-5a is part of the subgroup of Wnts that are not axis-inducing in Xenopus embryos and do not transform C57MG mammary epithelial cells. This subgroup is also implicated in the Wnt/Ca2+ pathway, playing roles in cell movements and cell adhesion (3). This non-canonical Wnt pathway can inhibit canonical Wnt/ beta -catenin signaling. In Wnt-5a deficient mouse embryos, beta -catenin accumulates in the limb bud suggesting that Wnt-5a normally promotes degradation of beta -catenin (4). Likewise, in Xenopus embryos Wnt-5a antagonizes the ability of the canonical Wnt subgroup to induce a secondary axis (5). Wnt-5a is implicated in various types of cancer and has complex roles. It acts as a tumor suppressor for mammary, B-cell, colon, and uroepithelial cancer cells but is up-regulated in melanomas, where expression levels correlate with severity of metastasis (3). Furthermore, aberrant Wnt-5a signaling results in other diseases such as rheumatoid arthritis (6). Like other developmental growth factors Wnt-5a has diverse roles in development. They are too numerous to enunciate here, as functions span from early anterior-posterior development and gastrulation movements to maintaining hematopoietic stem cell population, lung morphogenesis, and limb outgrowth. Mouse and human Wnt-5a share 97% amino acid identity.

References

Miller, J.R. (2002) Genome Biol. 3:3001.
Roelink, H. and R. Nusse (1991) Genes Dev. 5:381.
Veeman, M.T. et al. (2003) Developmental Cell 5:367.
Topol, L. et al. (2003) J. Cell Biol 162:899.
Torres, M. et al. (1996) J. Cell Biol. 133:1123.
Sen, M. et al. (2001) Arthritis & Rheumatism 44:772.

Long Name

Wingless-type MMTV Integration Site Family, Member 5a

Entrez Gene IDs

7474 (Human); 22418 (Mouse)

Alternate Names

hWNT5A; protein Wnt-5a; wingless-type MMTV integration site family, member 5A; WNT-5A protein; Wnt5a; Wnt-5a

Product Datasheets

Product Datasheet

COA

SDS

Related Research Areas

Citations for Mouse Wnt-5a Biotinylated Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

9 Citations: Showing 1 - 9
Filter your results:

Filter by:

Stromal changes in the aged lung induce an emergence from melanoma dormancy
Authors: ME Fane, Y Chhabra, GM Alicea, DA Maranto, SM Douglass, MR Webster, VW Rebecca, GE Marino, F Almeida, BL Ecker, DJ Zabransky, L Hüser, T Beer, HY Tang, A Kossenkov, M Herlyn, DW Speicher, W Xu, X Xu, EM Jaffee, JA Aguirre-Gh, AT Weeraratna
Nature, 2022-06-01;606(7913):396-405.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Western Blot
Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity
Authors: Douglass SM, Fane ME, Sanseviero E et al.
Cancer Research
ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma
Authors: A Ndoye, A Budina-Kol, CH Kugel, MR Webster, A Kaur, R Behera, VW Rebecca, L Li, PA Brafford, Q Liu, YN Vashisht G, MA Davies, GB Mills, X Xu, H Wu, M Herlyn, MC Nicastri, JD Winkler, MS Soengas, RK Amaravadi, ME Murphy, AT Weeraratna
Cancer Res., 2017-09-08;0(0):.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot
Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho
Authors: R Behera, A Kaur, MR Webster, S Kim, A Ndoye, CH Kugel, GM Alicea, JX Wang, K Ghosh, PF Cheng, S Lisanti, K Marchbank, V Dang, MP Levesque, R Dummer, X Xu, M Heryn, AE Aplin, A Roesch, MC Caino, DC Altieri, AT Weeraratna
Clin. Cancer Res, 2017-02-23;0(0):.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot
The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report
Authors: Ossia M. Eichhoff, Marie C. Zipser, Mai Xu, Ashani T. Weeraratna, Daniela Mihic, Reinhard Dummer et al.
Melanoma Research
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
Authors: O'Connell MP, Fiori JL, Xu M
Oncogene, 2009-10-05;29(1):34-44.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot
Wnt5A activates the calpain-mediated cleavage of filamin A.
Authors: O'Connell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC, Frank BP, Earley R, Hoek KS, Hasskamp JH, Elias EG, Taub DD, Bernier M, Weeraratna AT
J. Invest. Dermatol., 2009-01-29;129(7):1782-9.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma
Authors: Webster MR, Fane ME, Alicea GM
Mol. Cell
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.
Authors: Fane, M E, Ecker, B L Et al.
Clin Cancer Res